公司資料
VYNE Therapeutics Inc. 股價、新聞與催化劑
- 股票代碼:
- VYNE
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
28.56 USD (+12.22%)
收盤價
最後更新: 2026年7月27日
22.5M USD
市值
股價為何變動
Current closing-price context is not available for VYNE.
公司概覽
業務概覽
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
所在地與產業分類
VYNE is headquartered in the United States and listed on NASDAQ. It sits in specialty dermatology biotechnology.
商業模式特徵
The company depends on clinical progress, formulation or mechanism differentiation, and capital efficiency. Investors typically watch data updates and the company's ability to sharpen its dermatology franchise.
生技產業定位
VYNE occupies a focused dermatology niche within biotech. The stock is driven by whether its skin-disease programs can create durable differentiation.
未來催化劑
- VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。